Accordingly, gut dysbiosis in patients with NASH-HCC resulted in peripheral immunosuppression (reduced CD8+ T cells and antigen-presenting cells, increased regulatory T cells)—at least partly via increased short-chain fatty acid production84 (Figure 2). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.